Proteoglycan 4 (PRG4) treatment enhances wound closure and tissue regeneration

• Published in: npj Regenerative medicine 2022-06, Vol.7 (1), p.32-32, Article 32
• Main Authors: Krawetz, Roman J., Abubacker, Saleem, Leonard, Catherine, Masson, Anand O., Shah, Sophia, Narendran, Nadia, Tailor, Pankaj, Regmi, Suresh C., Labit, Elodie, Ninkovic, Nicoletta, Corpuz, Jessica May, Ito, Kenichi, Underhill, T. Michael, Salo, Paul T., Schmidt, Tannin A., Biernaskie, Jeff A.
• Format: Article
• Language: English
• Subjects: 631/532/2074; 631/532/489; 692/698/1671/1354; Biomaterials; Biomedical and Life Sciences; Biomedicine; Cartilage; Cell Biology; Immunology; Regenerative Medicine/Tissue Engineering; Stem Cells; Tissue engineering; Wound healing
• ISSN: 2057-3995; 2057-3995
• DOI: 10.1038/s41536-022-00228-5

The wound healing response is one of most primitive and conserved physiological responses in the animal kingdom, as restoring tissue integrity/homeostasis can be the difference between life and death. Wound healing in mammals is mediated by immune cells and inflammatory signaling molecules that regulate tissue resident cells, including local progenitor cells, to mediate closure of the wound through formation of a scar. Proteoglycan 4 (PRG4), a protein found throughout the animal kingdom from fish to elephants, is best known as a glycoprotein that reduces friction between articulating surfaces (e.g. cartilage). Previously, PRG4 was also shown to regulate the inflammatory and fibrotic response. Based on this, we asked whether PRG4 plays a role in the wound healing response. Using an ear wound model, topical application of exogenous recombinant human (rh)PRG4 hastened wound closure and enhanced tissue regeneration. Our results also suggest that rhPRG4 may impact the fibrotic response, angiogenesis/blood flow to the injury site, macrophage inflammatory dynamics, recruitment of immune and increased proliferation of adult mesenchymal progenitor cells (MPCs) and promoting chondrogenic differentiation of MPCs to form the auricular cartilage scaffold of the injured ear. These results suggest that PRG4 has the potential to suppress scar formation while enhancing connective tissue regeneration post-injury by modulating aspects of each wound healing stage (blood clotting, inflammation, tissue generation and tissue remodeling). Therefore, we propose that rhPRG4 may represent a potential therapy to mitigate scar and improve wound healing.